Skip to main content
Tallo logoTallo logo
Apply for this opportunity

This job application is on an outside website. Be sure to review the job posting there to verify it's the same.

Apply Offsite

Director, Biostats

Job

The Lotus Group LLC

Watertown, MA (In Person)

Full-Time

Posted 4 weeks ago (Updated 2 weeks ago) • Actively hiring

Expires 7/21/2026

Review key factors to help you decide if the role fits your goals.
How is this calculated?
Pay Growth
?
out of 5
Not enough data
Not enough info to score pay or growth
Job Security
?
out of 5
Not enough data
Calculating job security score...
Total Score
100
out of 100
Average of individual scores

Were these scores useful?

Skill Insights

Compare your current skills to what this opportunity needs—we'll show you what you already have and what could strengthen your application.

Job Description

Director, Biostats at The Lotus Group LLC Director, Biostats at The Lotus Group LLC in Watertown, Massachusetts Posted in 12 days ago.
Type:
full-time
Job Description:
We are seeking an experienced Director of Biostatistics to lead statistical strategy and execution for complex, late-stage clinical development programs. In this role, you will design innovative clinical trials, author statistical sections of protocols and analysis plans, oversee the implementation and quality of statistical analyses, and interpret results to support global regulatory submissions and scientific publications. You will partner cross-functionally with clinical, regulatory, data management, and programming teams to drive high-quality, timely deliverables, while also representing the organization in interactions with regulatory authorities and external stakeholders. The ideal candidate holds a Ph.D. in Statistics or Biostatistics (or equivalent) and brings 8-10+ years of industry experience, including leadership in Phase 2/3 studies, regulatory submissions, and advanced methodologies such as Bayesian or adaptive designs, along with strong communication skills and proficiency in SAS and R. Our client is a mid-sized pharma co; TA metabolic programs.